CORMORANT ASSET MANAGEMENT, LP Keros Therapeutics, Inc. Transaction History

CORMORANT ASSET MANAGEMENT, LP portfolio value:

$3.76M
portfolio value

CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:

+36.16%
quarter

Keros Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 999K $37.62 100K
Q2 2022 share 0.00% 0 shares -2.67M $27.63 100K
Q1 2022 share Decrease -33.33% -50K shares -3.33M $54.38 100K
Q4 2021 share Increase 0.00% 150K shares 8.77M $56.3 150K